title: Lipohypertrophy in acromegaly induced by the new growth hormone receptor antagonist pegvisomant.
authors.forename: Pietro
authors.initials: P
authors.lastname: Maffei
authors.forename: Chiara
authors.initials: C
authors.lastname: Martini
authors.forename: Claudio
authors.initials: C
authors.lastname: Pagano
authors.forename: Nicola
authors.initials: N
authors.lastname: Sicolo
authors.forename: Francesco
authors.initials: F
authors.lastname: Corbetti
mesh_terms: D000005:Abdomen; D000172:Acromegaly / Q000188:drug therapy*; D000273:Adipose Tissue / Q000473:pathology*; D000328:Adult; D005260:Female; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D006984:Hypertrophy; D007279:Injections, Subcutaneous / Q000009:adverse effects; D008060:Lipodystrophy / Q000139:chemically induced*; D008297:Male
chemical_list: D019382:Human Growth Hormone; C406545:pegvisomant